This study will evaluate the effectiveness of a single dose of Baloxavir Marboxil to prevent the spread of influenza virus infection - Trial 2020-000696-20
Access comprehensive clinical trial information for 2020-000696-20 through Pure Global AI's free database. This phase not specified trial is sponsored by Shionogi & Co., Ltd. and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2020-000696-20
Trial Details
EU Clinical Trials Register • 2020-000696-20
This study will evaluate the effectiveness of a single dose of Baloxavir Marboxil to prevent the spread of influenza virus infection
Study Focus
Sponsor & Location
Shionogi & Co., Ltd.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Proportion of subjects who are infected with influenza virus (RT-PCR positive), and present with fever and at least one respiratory symptom
ICD-10 Classifications
Influenza and pneumonia
Influenza due to identified seasonal influenza virus
Influenza with other manifestations, seasonal influenza virus identified
Influenza with pneumonia, seasonal influenza virus identified
Influenza due to identified zoonotic or pandemic influenza virus
Data Source
EU Clinical Trials Register
2020-000696-20
Non-Device Trial